Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial()

por McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.
Publicado 2020

The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies

por Phillips, E. H., Westwood, J. P., Brocklebank, V., Wong, E. K. S., Tellez, J. O., Marchbank, K. J., McGuckin, S., Gale, D. P., Connolly, J., Goodship, T. H. J., Kavanagh, D., Scully, M. A.
Publicado 2016